The affected products include:
- Forty-two lots of 8.4 percent sodium bicarbonate injection 50 mL vials
- Five lots of NeutTM 5 mL vials
- Five lots of QuelicinTM 10 mL vials
- Seven lots of potassium phosphates injection 45 mM vials
The recall comes after a routine simulation of the manufacturing process uncovered the potential for microbial growth, meaning microorganisms may be in the products. However, microorganisms have not been detected in actual batches of the solutions, and no adverse events have been reported to Hospira.
Organizations with any of the affected products should stop use and quarantine them immediately, according to the recall notice.
See the full recall notice, posted by the Food and Drug Administration, here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
